Analyst firms · Needham · RVMD
Needham RVMD price target and rating history
Revolution Medicines Inc. (RVMD) · Health Care
Needham rates Revolution Medicines Inc. (RVMD) Buy with a $62 price target, as of its latest action on Jul 16, 2024. It has published 3 rating actions on RVMD since December 2022, including 0 upgrades and 0 downgrades. Across 6 firms with a RVMD price target in the last 12 months, the median target is $165.
- Current rating
- Buy
- Price target
- $62
- Median target, all firms
- $165
- Actions on RVMD
- 3
Needham price target on RVMD
Every Needham rating on RVMD
- Jul 16, 2024
- Apr 12, 2024
- Dec 14, 2022
How other firms rate RVMD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| William Blair | Outperform | Oct 16, 2026 | |
| Goldman Sachs | Buy | $267 | Sep 24, 2026 |
| Morgan Stanley | Overweight | $255 | Sep 10, 2026 |
| Bernstein | Mkt Perform | $151 | May 22, 2026 |
| Truist Securities | Buy | $179 | May 18, 2026 |
| Jefferies | Buy | Mar 16, 2026 | |
| UBS | Buy | $145 | Feb 27, 2026 |
| Wolfe Research | Outperform | $75 | Nov 18, 2025 |
Questions about Needham and RVMD
- What is Needham's price target for RVMD?
- Needham's latest stated price target for Revolution Medicines Inc. (RVMD) is $62, from its action on Jul 16, 2024.
- What is Needham's rating on RVMD?
- Needham rates RVMD Buy, a bullish rating, as of Jul 16, 2024.
- When did Needham last change its view on RVMD?
- On Jul 16, 2024, Needham raises its price target to $62 from $46, keeps Buy.
- How does Needham's RVMD target compare with other analysts?
- Across 6 firms with a RVMD price target in the last 12 months, the median target is $165.
More RVMD rating histories
All Needham ratingsRVMD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.